Overview of Up First by NPR
This episode covers three major stories: the latest primary election results, concerns that U.S. missile stockpiles are being strained by the war with Iran, and a potential FDA decision on the first mRNA-based flu vaccine. The political segment focuses on what Democratic and Republican primary outcomes may signal about voter mood heading into November, while the security and health segments examine how military readiness and vaccine technology are being shaped by larger strategic and political pressures.
Primary Election Results and What They Mean
Michigan Senate Primary Still Too Close to Call
- In Michigan’s closely watched Democratic Senate primary, Abdul El-Sayed held a narrow lead over Rep. Haley Stevens.
- El-Sayed is described as a more progressive, outsider-style candidate, while Stevens is more moderate and establishment-aligned.
- The race was seen as a key test of whether Democrats are leaning more toward progressive or moderate candidates, but the broader takeaway is that voters are also rejecting the party establishment itself.
Broader Democratic and Republican Signals
- NPR’s Tamara Keith noted that the result suggests Democratic primary voters are less persuaded by moderation than they were in 2018.
- The primary was bitter enough that some voters may resist supporting the eventual nominee in November, which could hurt Democrats’ chances in a must-win race.
- On the Republican side, former Rep. Mike Rogers, backed by Donald Trump, won the GOP nomination and will face the Democratic winner.
- Republicans see Michigan as a pickup opportunity, but Rogers may face challenges because of the anti-establishment mood and the unpopularity of the president.
Other Races and Outside Spending
- In Michigan’s 7th Congressional District, Democrats nominated William Lawrence, a progressive outsider in a true toss-up seat.
- In Washington state, Rep. Marie Gluesenkamp Perez defeated a progressive challenger.
- The episode also highlights the impact of AIPAC-linked spending:
- A pro-Israel group tied to AIPAC reportedly spent $32 million to support Haley Stevens in Michigan.
- That investment could become a major loss if Stevens falls short.
- But in Missouri, Rep. Wesley Bell, also favored by AIPAC-linked spending, easily defeated Cori Bush, showing that the group’s influence has been mixed rather than uniformly decisive.
U.S. Missile Stockpiles Running Low
What’s in Short Supply
- NPR reports that the U.S. Army has used up much of its supply of long-range precision missiles in the war with Iran.
- The missiles specifically mentioned include:
- ATACMS (Army Tactical Missile System)
- PrSM (Precision Strike Missile)
- These are offensive weapons that can hit targets from hundreds of miles away and reduce the need to put U.S. pilots or troops near enemy defenses.
Why It Matters
- Although the Pentagon does not publicly disclose exact stockpile numbers, the concern is that these weapons take years to replenish.
- Even if the U.S. has enough for current operations, military planners worry about what happens if a major conflict emerges suddenly, including a potential crisis involving China and Taiwan.
Defensive Interceptors Are Also Depleted
- A separate concern is the drop in Patriot missile interceptors, which are used to shoot down incoming drones and missiles.
- A CSIS report found U.S. Patriot stockpiles have fallen by about two-thirds since the war began.
- Each Patriot interceptor costs around $4 million, while many of the drones it shoots down cost only $20,000–$30,000, creating a huge cost imbalance.
Official Reaction
- Public comments from the Trump administration have been mixed.
- Defense Secretary Pete Hegseth previously dismissed depletion reports as exaggerated, but also acknowledged replenishment could take months or years.
- The shortage has broader implications because Ukraine also needs Patriot missiles to defend against Russian attacks.
FDA Decision on First mRNA Flu Vaccine
What the Vaccine Is
- The FDA is expected to decide whether to approve the first mRNA flu vaccine, developed by Moderna.
- The episode describes it as working similarly to Moderna’s COVID-19 mRNA vaccine: it teaches the immune system to produce antibodies against flu viruses.
Why Supporters Are Optimistic
- Moderna tested the vaccine in more than 40,000 people.
- Results suggest it is safe and may provide stronger protection than traditional flu shots, especially for adults 50 and older.
- FDA advisers already voted unanimously to recommend approval.
Why It’s Important
- mRNA vaccines can be updated faster when flu strains change.
- They can also be manufactured more quickly than traditional flu vaccines.
- Supporters say this could be a major advance, especially if a future flu pandemic emerges.
Political and Ideological Controversy
- mRNA technology remains highly controversial because of backlash over COVID-era mandates and misinformation.
- Health Secretary Robert F. Kennedy Jr. and other Trump officials have been openly hostile to mRNA vaccines.
- The administration has made COVID shots harder to get and cut funding for mRNA research.
- The FDA originally declined to review the flu vaccine, then reversed course after criticism.
Opponents’ View
- An anti-vaccine representative from Children’s Health Defense argued the technology is too new and insufficiently studied.
- The episode frames the FDA decision as a test of whether the agency will follow its own scientific advisers despite political pressure.
Key Takeaways
- Michigan’s Democratic Senate primary reflects a broader fight over ideology, establishment politics, and electability.
- AIPAC-linked spending had some major wins but also faces possible setbacks, especially if Haley Stevens loses.
- The U.S. is under real strain from missile depletion, affecting both offensive and defensive stockpiles.
- A possible mRNA flu vaccine approval could reshape flu prevention, but it remains politically charged under RFK Jr.’s health leadership.